
Bulletin of the Chemical Society of Japan p. 3457 - 3464 (1985)
Update date:2022-08-04
Topics:
Nakata
Toshima
Kai
Kinoshita
The improved practical synthesis of 6,8,10-tri-O-acetyl-3-C-(acetoxymethyl)-3,5,7,9,11-pentadeoxy-1,2-O-isopro pylidene-5,7,9,11-tetra-C-methyl-L-erythro-D-altro-β-L-talo-dodecodialdof uranose-(1,4) 12-(diethyl acetal) (3), a useful synthetic segment for the rifamycin W ansa-chain, is described. The key intermediate, 3-O-benzyl-2,4,7-trideoxy-5,6-O-isopropylidene-2,4-di-C-methyl-aldehydo-D- glycero-D-allo-heptose (22), was synthesized in a 29.4% yield from methyl 4,6-O-benzylidene-3-deoxy-3-C-methyl-α-D-altropyranoside (8) in 15 steps. The coupling of 22 with the lithium reagent prepared from butyllithium and 3-C-(benzyloxymethyl)-3,5,6-trideoxy-5-iodo-1,2-O-isopropylidene-α-D-ribo -5-hexenofuranose afforded only the 'Cram' product 24 in a 61% yield. The homogeneous hydrogenation of 24 with [RhCl(Ph3P)3] gave 8-O-benzyl-3-C-(benzyloxymethyl)-3,5,7,9,12-pentadeoxy-1,2:5,6-di-O-isopro pylidene-5,7,9-tri-C-methyl-D-erythro-D-altro-L-talo-dodecofuranose-(1,4) (25) and its C-5 epimer in 95 and 3.8% yields respectively. 6,8-Di-O-benzyl-3-C-(benzyloxymethyl)-3,5,7,9-tetradeoxy-1,2-O-isopropylid ene-5,7,9-tri-C-methyl-D-altro-β-L-talo-decodialdofuranose-(1,4), derived from 25 in a 91% yield, was subjected to coupling with 3,3-diethoxy-2-lithio-1-propene to afford about 1.7:1 excess of the 'Cram' product (30, 59% yield). The conversion of 30 into 3 was accomplished by the sequence of reactions involving homogeneous hydrogenation, debenzylation, and acetylation in a 75% yield. The 24-step synthesis of 3 from 8 was achieved in a 7% overall yield.
View MoreChangsha Yihai Chemical Technology Co.,ltd
website:http://www.cs-yihai.com/
Contact:0731- 85620465
Address:Room 23005, unit 2, the northern building of Xiangsong international building , NO.259 Shaoshan Road , Changsha , Hunan, China.(mainland)
QINGDAO NEW FLOURISH INTERNATIOANAL TRADE CO., LTD.
Contact:+86 532 80861829
Address:No. 1, Yinchuan East Road, 266061, Qingdao, China
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Jinhua City Mingzhu Pharmaceutical Co.,Ltd.
Contact:15857995878 0579-82207761
Address:No.169 Shenze Road, New Area,Jinpan Development Zone, Jinhua
PharmaResources(Kaiyuan)CO,.Ltd
Contact:+86-21-50720028
Address:No.3, Beihuan Road, Economic Development District, Kaiyuan City, Tieling City, Liaoning Province, China 112300
Doi:10.1016/j.bmc.2008.05.031
(2008)Doi:10.1016/j.tetlet.2008.04.130
(2008)Doi:10.1021/ol801358c
(2008)Doi:10.1016/S0040-4039(00)83948-9
(1986)Doi:10.1007/s10593-007-0140-8
(2007)Doi:10.1021/ol800902g
(2008)